Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)
Clinical trial NCT03542461 · UNKNOWN
Trial details
- NCT number
- NCT03542461
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2023-01-31
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.